Skip to content
GLP-1 Scorecard
Menu
Graded #8

telos rx

A LegitScript-certified, HIPAA telehealth with one of the deepest published catalogs in the ranking — compounded semaglutide and tirzepatide (oral and microdosed routes included) alongside PT-141, intranasal NAD+, and a long recovery/GH peptide bench — with compounded GLP-1 starting from $49/mo on an annual plan.

Visit telos rxWe may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Semaglutide
$99/mo injectable — the $49 headline is only the FIRST month of the 12-month prepaid ORAL plan, which renews at $129/mo billed every 48 weeks
Tirzepatide
$139/mo injectable · $129/mo oral · $116/mo microdosed (microdosing is tirzepatide, not semaglutide)
Coverage
Not publicly listed
Brand-name
Compounded only

Weigh telos rx against the full graded field on the best semaglutide providers scorecard, or line it up against its closest alternatives. Because telos rx dispenses compounded medication, it’s worth understanding whether compounded semaglutide is legit and safe.

Factor breakdown

Each of the six graded dimensions. See the methodology.

Cost value87/100
Dose & formulation90/100
Clinical oversight84/100
Labs & monitoring80/100
Fulfillment87/100
Contract terms80/100

Strengths

  • Deep published catalog — sema, tirz, PT-141, intranasal NAD+, recovery/GH peptides, GHK-Cu, Dihexa, HRT
  • Needle-free and oral GLP-1 options, not injection-only
  • LegitScript-certified and HIPAA, with US providers and pharmacies, HSA/FSA and free shipping
  • Low GLP-1 entry — from $49/mo microdosed on an annual plan

Where it loses points

  • Everything is compounded and not FDA-approved, including the peptides
  • Pricing is opaque outside GLP-1 and the lowest rates require annual lock-in
  • No named clinicians and thin third-party reviews
  • Several research-grade peptides carry limited clinical evidence

Bottom line — Grade B

Best for: Patients who want a broad compounded menu — needle-free or oral GLP-1 plus peptides and HRT — from a LegitScript-certified operator, and who are comfortable with annual lock-in to hit the lowest entry pricing.

Ranked #8 of 536 on this scorecard. See our top-scoring pick, CoreAge Rx (#1), for comparison.

Closest here

The rankings grading nearest telos rx — the realistic shortlist.

The 19 rankings nearest this one

View full scorecard rankings →

Pricing/verification reflect telos rx's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on telos rx's site. Not medical advice; see our disclosure.

← Back to the scorecard